| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.5M | +13.5% | +9.0% |
| Cost of Revenue | $3.3M | -7.7% | +33.6% |
| Gross Profit | $24.2M | +17.1% | +6.4% |
| R&D Expense | $14.0M | -25.9% | +23.4% |
| SG&A Expense | $37.6M | -13.0% | +29.9% |
| Operating Income | -$27.4M | +33.9% | -56.1% |
| Pre-tax Income | -$34.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $90.0M | -3.1% | -27.9% |
| Short-term Investments | $63.8M | -23.2% | -58.6% |
| Accounts Receivable | $19.7M | +0.3% | -13.6% |
| Inventory | $8.3M | +17.0% | +9.8% |
| Current Assets | $168.5M | -14.4% | -42.9% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$124.1M | — | — |
| Capital Expenditures | $272K | — | — |
| Investing Cash Flow | $33.8M | — | — |
| Financing Cash Flow | $8.6M | — | — |
| Free Cash Flow | -$124.4M | — | — |
| +29.7% |
| -45.9% |
| Income Tax | -$1.1M | -203.8% | -1258.2% |
| Net Income | -$33.3M | +33.2% | -40.9% |
| EPS (Basic) | -$0.69 | +34.3% | -25.5% |
| $185.0M |
| -11.3% |
| -38.7% |
| Current Liabilities | $42.2M | -11.2% | +28.8% |
| Long-term Debt | $122.1M | -0.3% | +0.3% |
| Total Liabilities | $300.5M | -0.5% | +8.7% |
| Stockholders' Equity | -$115.4M | -23.6% | -552.3% |